Skip to main content
. 2016 Oct;10(4):542–547.

Table 2.

The mean ± SEM Monocyte count (×103) per μl, Pre and post chemotherapy of cancer patients on the treatment protocol of vinorelbine (Group I), vinorelbine based combinations(Group II) and overall total (60) patients.

Time (week) Monocyte count (×103) per μl in Group-I Monocyte count (×103) per μl Group-II Overall Monocyte count (×103) per μl P value2
Mean ± SEM Mean ± SEM Mean ± SEM
Week 0 0.4621 0.0343490 0.42330 0.0495568 0.4519 0.0283423 0.551
Week 1 0.1786 0.0197340 0.10400 0.0544390 0.1593 0.0204869 0.112
Week 2 0.2129 0.0346626 0.17266 0.0621555 0.2021 0.0301487 0.559
Week 3 0.1716 0.0247280 0.24666 0.0774140 0.1900 0.0265393 0.372
Week 4 0.2246 0.0380977 0.17000 0.0474040 0.2120 0.0312281 0.468
P value1 <0.001 0.08 <0.001
P value3 <0.001 0.053

P value1 -represent an overall comparison of mean values over time,

P value2 -represent the independent comparison of mean values for two groups at every week

P value3 -represent a comparison of mean values observed before therapy with that of week 4 (after therapy)

p< 0.001 considered extremely significant and p < 0.05 considered significant

All values are expressed in Mean ± SEM, n = 60